Epigenetic Products Overview


Rockland continues to innovate and drive thought leadership in antibody science, as well as the technology important to the future of the industry. Rockland offers an extensive antibody portfolio encompassing antibody probes specific to Epigenetics.


View All Epigenetic Antibodies 
Multicomponent cellular machinery referred to as readers, writers and erasers, are responsible for altering gene expression patterns and determining the cellular phenotype without changing the genetic information encoded in the nucleotide sequence. The regulation is dynamic, reversible and establishes normal cellular phenotypes but also contribute to human disease. Termed "Epigenetics", this process can be described as a regulation from above, resulting in functionality relevant modifications to the genetic material without alteration of the primary DNA sequence. Epigenetic mechanisms are influenced by several factors including development in utero, childhood, aging, diet, as well as environmental chemicals, drugs used, and lifestyle. These modifications are inheritable, ensuring continued guidance of gene expression resulting in the many cellular differentiation processes that make up an organism.

Additional Resources

Rockland Immunochemicals was a proud sponsor of The Scientist's Spotlight on Epigenetics Drug Discovery. This webinar brings together a panel of experts to address some of the key questions that the field of epigenetics is grappling with today.

MARGARET PORTER-SCOTT, PhD, Senior Director, Lead Discovery, Epizyme Inc.
JATINDER SINGH, PhD, Principal Scientist, Drug Safety and Metabolism, AstraZeneca Pharmaceuticals




Protein Modification


Post-translational modification of histones, including methylation, acetylation, phosphorylation and ubiquitination. Arginine or lysine amino acids within the protein sequence represent the targets at which methylation can occur. Varying degrees of reversible methylation are mediated by peptidylarginine or lysine methyltransferases, in which up to two or three methyl groups can be added to arginine or lysine residues respectively. Because methylation does not change the charged state of a lysine or arginine residue, it does not appear to directly effect chromatin structure. Instead, the various methyl marks act as binding sites for other proteins to chromatin sites marked by methylation. Methylated histones can be methylation.
Histone acetylation is regulated by two families of enzymes: histone acetyltransferases (HATs) and HDAC. As a result of Lysine acetylation via HATs, chromatin adopts a more relaxed structure, enabling the recruitment of the transcriptional machinery. HDACs oppose the effects of HATs and reverse the acetylation of lysine residues to restore their positive charge and stabilize the local chromatin architecture.

 Epi-Plus Histone





Rockland offers an assortment of Chromatin Immunoprecipitation (ChIP)-specific antibodies enabling the study of protein-DNA interactions by immuno-precipitation. The existing antibody probes offer assistance in the identification of target locations within the genome that various histone modifications are associated




DNA Methylation  

DNA methylation is an important epigenetic modification involving the addition of a methyl group from S-adenosyl-L-methionine to the fifth carbon position of cytosine, thus forming 5-methylcytosine via numerous types of methyltransferases. This reversible process predominantly occurs within the CG-rich regions, where cytosine nucleotides are directly followed by guanidine nucleotides and is mediated by enzymes referred to a DNA methyltransferases (readers and writers). The degree of DNA methylation is inversely proportional to the transcriptional activity of genes, where heavily methylated genes are less transcribed than non-methylated nucleotide regions of the genome; with promoter regions almost always displaying no methylation events at all - termed CpG islands.




Epigenetic Peptides

To support epigenetic research and our Epi-Plus antibodies, Rockland offers a comprehensive group of peptides to provide a one stop shop for epigenetic researchers.

Epigenetics (“above” genetics) is the study of DNA, RNA and protein modifications that do not involve changes in gene sequences.  The modifications involve the acetylation and/or methylation of DNA or protein and are referred to as “Epigenetic marks”.  These marks, studied primarily in histones and other proteins that control the regulation of gene expression, transcription, and protein-protein interaction, have been implicated in an array of human pathophysiological conditions that includes cancer, obesity, diabetes, drug addiction (and addictive phenotypes in general), and post-traumatic stress disorder.  The pattern of Epigenetic marks on histones coordinate the binding of repressors, activators, and other proteins.  Current research is focused on understanding how specific patterns of marks can act in a coordinated fashion to generate a specific phenotype.  



The Rockland Advantage: Epigenetics

At Rockland, we have produced antibodies specifically for epigenetics that are unique to the research community.  These antibodies are multi-assay validated prior to release and are validated for performance in multiple species.  But there is more to this story.  The quality of our starting reagents, the proper controls during antibody manufacture and the proper quality control testing prior to release are all part of this success story.  Find out more about Rockland’s superior antibodies for epigenetics research.  Compromise elsewhere.



Epigenetic Button



Localization of HDAC1 poster

View the Rockland & Leica HDAC Poster





Epigenetics Poster Icon



PDF iconClick here to download

the modified histone map poster





Epigenetic Antibodies PDF